Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

NCT02163902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Submental Fat
Healthy

Interventions

DRUG: ATX-101
DRUG: Placebo

Sponsor

Kythera Biopharmaceuticals